menu search

Moderna sues pfizer after saying it wouldn't enforce its patents for covid-19 vaccine technology

Moderna is suing competing vaccine maker Pfizer and its German partner BioNTech, alleging the pharmaceutical...

August 26, 2022, 9:05 am

Why aerie pharmaceuticals was soaring so high this week

You'd vault skyward, too, if a big-pocketed company were willing to spend a lot of coin on acquiring you....

August 26, 2022, 9:03 am

Forget bargain hunting: play 5 stocks with rising p/e

Bet on these top-ranked stocks with rising P/E to realize outsized gains. Tap Eastside Distilling (EAST), Adial ...

August 26, 2022, 9:02 am

Aptorum group limited to present at the h.c. wainwright annual global investment conference, september 13-16, 2022

NEW YORK & LONDON & PARIS--(BUSINESS WIRE)--Aptorum Group Limited (Nasdaq: APM, Euronext Paris: APM) a clinical stage bio...

August 25, 2022, 8:31 pm

Rocket pharmaceuticals: updates to thesis, clinical momentum continues to accelerate

Shares have lost 15% year to date. Company wisely adopted a platform-agnostic approach to address first-in-class opportunities across the gene therapy...

August 25, 2022, 4:07 pm

Mind medicine ($mnmd) doses first patient in phase 2b trial to treat generalized anxiety disorder

Mind Medicine ($MNMD) a clinical stage biopharmaceutical company developing novel products to treat bra...

August 25, 2022, 3:58 pm

Clearside biomedical to present at the ophthalmology futures retina forum 2022

ALPHARETTA, Ga., Aug. 25, 2022 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc. (NASDAQ:CLSD), a biopharmaceuti...

August 25, 2022, 7:05 am

Immuneering announces participation in september investor conferences

CAMBRIDGE, Mass., Aug. 25, 2022 (GLOBE NEWSWIRE) -- Immuneering Corporation (Nasdaq: IMRX), a biopharmaceutica...

August 25, 2022, 6:50 am

Positive abivertinib trial results push sorrento therapeutics (srne) 6.2% higher

Biopharmaceutical outfit Sorrento Therapeutics (US:SRNE) rallied +6.2% on Tuesday and extended gains by...

August 24, 2022, 9:12 pm

Blue water vaccines to present at the universal influenza vaccines 2022 conference in oxford, united kingdom

CINCINNATI, Aug. 24, 2022 (GLOBE NEWSWIRE) -- Blue Water Vaccines Inc. (“BWV” or “Blue Water Vaccines” or “the Company”) a bio...

August 24, 2022, 2:00 pm

Jazz pharmaceuticals: monopoly in the narcolepsy drug market

Jazz has a monopoly on the market for narcolepsy drugs. Narcolepsy patients require daily medication to keep functioning properly throughout the day. ...

August 24, 2022, 8:35 am

Inmed pharmaceuticals (inm) stock: 1-for-25 split announced

InMed pharmaceuticals (INM) announced it will be consolidating all of its issued and outstanding share ...

August 24, 2022, 7:05 am

Alcon to acquire aerie pharmaceuticals for $15.25 a share

Alcon agrees to acquire Aerie, the ophthalmic therapies company, for $15.25 a share....

August 23, 2022, 3:45 am

Adial clinical trial: a fluff or a win?

Onward Phase III Clinical Trial of Adial pharmaceutical's AD04, a treatment for Alcohol Abuse Disorder,...

August 22, 2022, 1:46 pm

Canntab therapeutics provides update on recent product delivery of its cannabinoid solutions to the nova scotia liquor corporation

Canntab Therapeutics Limited has provided an update on the recent product delivery of its unique pharmaceutica...

August 22, 2022, 7:48 am

Bellus health to present clinical data from phase 2b soothe trial of blu-5937 at the european respiratory society international congress 2022

LAVAL, Quebec--(BUSINESS WIRE)--BELLUS Health Inc. (Nasdaq:BLU; TSX:BLU) (“BELLUS Health” or the “Company”), a clinical-stage bio...

August 22, 2022, 7:00 am

Novartis: undervalued swiss pharma giant

Novartis is a global healthcare company with a research-driven focus on pharmaceuticals, both prescript...

August 21, 2022, 3:51 am

Pfizer is a solid high-yielding idea

Pfizer is a high-quality, high-yielding pharmaceutical company backed up by a robust drug portfolio. We...

August 11, 2022, 12:50 pm

Rvl pharmaceuticals plc (rvlp) reports q2 loss, tops revenue estimates

RVL pharmaceuticals PLC (RVLP) delivered earnings and revenue surprises of 20.83% and 0.57%, respective...

August 11, 2022, 12:03 pm

Rvl pharmaceuticals plc (rvlp) ceo brian markison on q2 2022 results - earnings call transcript

RVL pharmaceuticals plc (NASDAQ:RVLP ) Q2 2022 Earnings Conference Call August 11, 2022 8:30 AM ET Comp...

August 11, 2022, 12:01 pm


Search within

Pages Search Results: